Some GLP-1s, like Ozempic, Mounjaro (tirzepatide), and Victoza (liraglutide), are approved to treat type 2 diabetes, meaning these medications are only prescribed if you have type 2 diabetes
Sep 2003;103(9):1199-1202
Differences Between Users and Nonusers Those who initiated GLP-1s differed significantly from those who did not: GLP-1 users vs nonusers were younger (mean age, 44.9 years vs 45.2 years), and use was more common among women vs men (15.1% vs 9.7%), among Black or African American vs White patients (15.8% vs 13.5%), and among those who underwent sleeve gastrectomy vs Roux-en-Y gastric bypass (14.9% vs 12.1%)
Cells continually regulate these forms, and researchers often use their relationship as one indicator of the cellular redox environment
In dogs, it may help with tissue repair, inflammation reduction, and age-related health issues
Quick eligibility & safety refresher (because expectations depend on fit) Source: FDA Who should consider GLP-1 medicines